Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilazodone vs Paroxetine in Geriatric Depression
NCT01608295Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jul 2012
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vilazodone in major depressive disorder (MDD) (2 arms), sponsored by University of California, Los Angeles. Primary endpoint: Hamilton Depression Rating Scale at 12 weeks. Started Jul 2012; status: completed.
02
Drugs
vilazodone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01608295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01608295.